Dr. Maria Teresa Landi
Senior Investigator, Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Dr. Landi is an M.D., Ph.D. with training in clinical oncology and molecular epidemiology and tenured Senior investigator at the National Cancer Institute, NIH.
She has focused her research on the environmental and genetic determinants of lung cancer and melanoma, and more recently on the genomic landscape of these tumors.
In lung cancer, she is currently leading two large population-based studies and uses next-generation sequencing and genome-wide analyses to explore lung cancer etiology and clonal evolution.
In her melanoma research, she investigates the relationship of UV radiation, genetic susceptibility and other host factors in population studies and in melanoma-prone families.
Title: Sherlock-Lung: Tracing lung cancer mutational processes in never smokers
Summary: Lung cancer in never smokers includes approximately 10-25% of all lung cancers worldwide, ranks among the most common causes of cancer mortality, and has a distinct natural history, restricted histological subtype (almost exclusively adenocarcinoma), different profile of oncogenic mutations, and response to targeted therapy compared to lung cancer in smokers.
Although few risk factors are known to contribute to the etiology of lung cancer in never smokers, a large fraction of cancer cases cannot be explained by established environmental and genetic risk factors, highlighting the need for research in this area.
One promising approach to identify the etiological factors involved in lung tumorigenesis in never smokers is based on the study of the “mutational signatures” that the exogeneous and endogenous processes leave on the tumor tissue and surrounding areas. I will describe the Sherlock-Lung study that was designed at the National Cancer Institute, NIH to implement this approach.
I will present preliminary results and possibilities for collaboration.
We have a number of membership categories available. Find out which membership suits you.
IACR Virtual Conference 2021
Highlighting the spectrum of cancer science, medicine and research across the island of Ireland.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
PhD in Tumour Immunology
A fully funded 4-year PhD studentship (€18,000 per annum stipend) is available in the research group of Dr. Aideen Ryan.
Education Grant 2020
The Irish Association for Cancer Research supported five Educational Grants in 2020. These were made available to postgraduate PhD researchers who had been affected by the Covid-19 pandemic.
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven